Nanosphere Cannabis International

Nanosphere Health Sciences is a biotechnology company specializing in the development of advanced drug delivery systems, most notably its patented NanoSphere Delivery System. This platform utilizes phospholipid nanoparticle (PLNP) technology to encapsulate bioactive compounds, such as cannabinoids, to enhance their bioavailability and efficacy. The company's primary commercial application is the Evolve Formulas brand, which offers transdermal gels and intranasal sprays designed to bypass the digestive system and first-pass metabolism. By providing rapid onset and precise dosing, Nanosphere aims to improve the therapeutic profile of both cannabis-based and traditional pharmaceutical products. However, the company has recently faced significant regulatory and financial hurdles, resulting in a suspension of its public trading status.